(S,R,S)-AHPC-PEG6-C4-Cl is a high-purity E3 Ligase Ligand-Linker Conjugate specifically designed for applications in PROTAC (Proteolysis Targeting Chimera) drug discovery and development. This molecule combines the selective binding capability of the VHL E3 ligase ligand (AHPC) with a flexible PEG6-C4 linker, terminated with a functional chloride handle for seamless conjugation to your target protein ligand. As a critical intermediate for assembling bifunctional degraders, (S,R,S)-AHPC-PEG6-C4-Cl facilitates the recruitment of the VHL E3 ubiquitin ligase complex, enabling targeted protein degradation through the ubiquitin-proteasome pathway. Widely used in academic and industry research, it supports the rapid development of next-generation therapeutic candidates aimed at undruggable protein targets. Ideal for medicinal chemistry and chemical biology teams focused on harnessing the power of protein degradation technologies in drug discovery.
Structure of 1835705-59-3
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-PEG6-C4-Cl is a specialized E3 ligase ligand-linker conjugate designed for targeted protein degradation. As a key component in the development of PROTAC (Proteolysis Targeting Chimera) molecules, it harnesses the specificity of E3 ligase binding to facilitate selective protein knockdown. The compound incorporates a high-affinity VH032-based VHL ligand (AHPC), optimized with a PEG6 linker for improved solubility and cellular permeability, and a functional C4-chloro handle for coupling to target-binding ligands.
Mechanism
(S,R,S)-AHPC-PEG6-C4-Cl operates as a modular E3 ligase ligand-linker, serving as one half of bifunctional PROTAC compounds. The AHPC moiety selectively recruits the von Hippel-Lindau (VHL) E3 ubiquitin ligase, while the PEG6 spacer affords flexibility and hydrophilicity. The terminal C4-chloro group enables conjugation with various target protein ligands. Once assembled into a complete PROTAC, the molecule brings the E3 ligase into proximity with the protein of interest, leading to its ubiquitination and subsequent proteasomal degradation.
Applications
(S,R,S)-AHPC-PEG6-C4-Cl is widely used in the creation and optimization of PROTACs aimed at targeted protein degradation for chemical biology research and drug discovery. Its versatile linker system supports conjugation to diverse small-molecule ligands, making it ideal for developing novel degraders against oncogenic proteins, epigenetic regulators, or other disease-relevant targets. Furthermore, it serves as a key reagent in structure-activity relationship (SAR) studies and mechanism-of-action assays in preclinical research.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.